• Home
  • About Us
  • Our People
  • Pipeline
  • News
  • Contact Us
Home
  • Home
  • About Us
  • Our People
  • Pipeline
  • News
  • Contact Us

Archives

Author Archive for: "Jane.Moate"
Home /
 Mr. Javier García
0
By Jane Moate
In
Posted 24th August 2021

Mr. Javier García

Dr Javier García Founder of Columbus Venture Partners Almost 30 years of experience working in healthcare and the biopharmaceutical industry. Since 2009, Mr. Garcia has focused on life science [...]

READ MORE
0
By Jane Moate
In News
Posted 7th July 2021

NeRRe Therapeutics raises £20 million in a Series B2 financing round

READ MORE
0
By Jane Moate
In News
Posted 20th January 2021

Dr Steve Pawsey, CMO at NeRRe Therapeutics to Present at The Eleventh International Cough Symposium

READ MORE
 Dr Mary Kerr, CEO of NeRRe Therapeutics to present at Biotech Showcase
0
By Jane Moate
In News
Posted 12th January 2021

Dr Mary Kerr, CEO of NeRRe Therapeutics to present at Biotech Showcase

READ MORE
0
By Jane Moate
In News
Posted 30th December 2019

Dr Mary Kerr, CEO of NeRRe Therapeutics to Present at Biotech Showcase in San Francisco on 13 January 2020

Dr Mary Kerr, CEO of NeRRe Therapeutics to present at Biotech Showcase in San Francisco on 13 January 2020, at 2.30PM, Franciscan C (Ballroom Level)

READ MORE
0
By Jane Moate
In News
Posted 30th September 2019

European Respiratory Society International Congress, Madrid 29 September 2019

European Respiratory Society International Congress, Madrid 29 September 2019 Dr Steve Pawsey, CMO at NeRRe Therapeutics presents a poster at the European Respiratory Society, Madrid 29 September [...]

READ MORE
0
By Jane Moate
In News
Posted 27th August 2019

NeRRe Therapeutics Announces Publication of Positive Results in a Phase 2 Pilot Study of Orvepitant in Chronic Refractory Cough

READ MORE
0
By Jane Moate
In News
Posted 7th June 2019

NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough

READ MORE
0
By Jane Moate
In News
Posted 4th January 2019

Dr Mary Kerr CEO NeRRe Therapeutics presents at the Biotech Showcase, San Francisco

8th January 2019: NeRRe Therapeutics CEO, Dr Mary Kerr, presents at the Biotech Showcase, 10:30 Franciscan – D (Ballroom Level), Hilton San Francisco, San Francisco, CA 94102, USA

READ MORE
0
By Jane Moate
In Company News
Posted 3rd December 2018

Dr Mike Trower CSO KaNDy Therapeutics will be giving an invited presentation entitled: ‘ Switching off the heat: A novel, rapidly acting and effective non-hormonal approach to treating hot flashes and other symptoms of the menopause with neurokinin-1,3 receptor antagonism’

READ MORE

NeRRe Logo

NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.

Useful Links
  • Contact Us
  • About Us
  • Privacy Policy
  • Cookie Notice
  • Terms & Conditions
  • Clinical Trials Privacy Notice
Contact Us
  • NeRRe Therapeutics
  • +44 (0) 1438 906 960
  • info@nerretherapeutics.com
  • www.nerretherapeutics.com
© 2018 NeRRe Therapeutics. All rights reserved. Website design by FDM Digital
Contact Us

Please fill out the form to get in touch with us.

Not readable? Change text. captcha txt

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy